Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer
Seongmin Cho, Hyeong Yun Kim, Nayoung Kim, Joohee Park, Seonghoon Kim, Ee Chan Song, Hyun Seo Lee, Uijoo Kim, Hamin Ban, Sunkyo Hwang, Jeongwon Mun, Eunhye Kwon, Yoonju Do, Hyo Eun Kim, Ji Hun Suh, Sang Bum Kim, Ina Yoon, Jiwon Kong, Minju Kang, Do Sik Min, Sunghoon Kim Cellular & Molecular Immunology
· Springer Nature
· 2026-10-27
· DOI: 10.1038/s41423-026-01480-1
Аннотация
Cellular & Molecular Immunology, Published online: 27 October 2026; doi:10.1038/s41423-026-01480-1 Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer
Seongmin Cho, Hyeong Yun Kim, Nayoung Kim, Joohee Park, Seonghoon Kim, Ee Chan Song et al. Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer. // Cellular & Molecular Immunology. – 2026. – DOI: 10.1038/s41423-026-01480-1. – URL: https://www.nature.com/articles/s41423-026-01480-1
Seongmin Cho, Hyeong Yun Kim, Nayoung Kim, Joohee Park, Seonghoon Kim, Ee Chan Song, Hyun Seo Lee, Uijoo Kim, Hamin Ban, Sunkyo Hwang, Jeongwon Mun, Eunhye Kwon, Yoonju Do, Hyo Eun Kim, Ji Hun Suh, Sang Bum Kim, Ina Yoon, Jiwon Kong, Minju Kang, Do Sik Min, & Sunghoon Kim (2026). Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-026-01480-1
Seongmin Cho, et al. “Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer.” Cellular & Molecular Immunology, 2026. doi:10.1038/s41423-026-01480-1.
@article{Cho2026,
title = {Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer},
author = {Cho, Seongmin and Kim, Hyeong Yun and Kim, Nayoung and Park, Joohee and Kim, Seonghoon and Song, Ee Chan and Lee, Hyun Seo and Kim, Uijoo and Ban, Hamin and Hwang, Sunkyo and Mun, Jeongwon and Kwon, Eunhye and Do, Yoonju and Kim, Hyo Eun and Suh, Ji Hun and Kim, Sang Bum and Yoon, Ina and Kong, Jiwon and Kang, Minju and Min, Do Sik and Kim, Sunghoon},
journal = {Cellular \& Molecular Immunology},
year = {2026},
doi = {10.1038/s41423-026-01480-1},
url = {https://www.nature.com/articles/s41423-026-01480-1}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’